Alessandra Catozzella, PhD’s Post

View profile for Alessandra Catozzella, PhD, graphic

Managing Director and Partner at Boston Consulting Group (BCG) | Healthcare & Public Sector | Digital and ESG passionate | Fortune Italia top 40 under 40

Generative AI is set to revolutionize health care, impacting everything from product development to precision medicine. As investors and companies position themselves to leverage this transformative technology, understanding both the opportunities and risks has never been more crucial. In this article, we dive deep into how GenAI is reshaping the industry and what it means for investors looking to stay ahead of the curve. Read the full article here: https://lnkd.in/dB4qyCfH

What GenAI Means for Health Care Investors

What GenAI Means for Health Care Investors

bcg.smh.re

Absolutely! GenAI's impact on healthcare is a game changer. Looking forward to seeing how it reshapes investment strategies!

Like
Reply

To view or add a comment, sign in

Explore topics